Finder is committed to editorial independence. While we receive compensation when you click links to partners, they do not influence our content.

How to buy Abiomed (ABMD) shares

Learn how to easily invest in Abiomed shares.

Abiomed is a medical devices business based in the US. Abiomed stocks (ABMD.US) are listed on the NASDAQ and all prices are listed in US Dollars. Its last market close was $253.79 – an increase of 10.6% over the previous week. Abiomed employs 0 staff and has a trailing 12-month revenue of around $1 billion.

How to buy stocks in Abiomed

  1. Compare stock trading platforms. Use our comparison table to help you find a platform that fits you.
  2. Open your brokerage account. Complete an application with your details.
  3. Confirm your payment details. Fund your account.
  4. Research the stock. Find the stock by name or ticker symbol – ABMD – and research it before deciding if it's a good investment for you.
  5. Purchase now or later. Buy your desired number of stocks with a market order or use a limit order to delay your purchase until the stock reaches a desired price.
  6. Check in on your investment. Optimize your portfolio by tracking your stock.

Abiomed stock price (NASDAQ:ABMD)

Use our graph to track the performance of ABMD stocks over time.

Abiomed shares at a glance

Information last updated 2022-05-15.
Latest market close$258.23
52-week range$227.25 - $379.30
50-day moving average $297.89
200-day moving average $323.46
Wall St. target price$354.17
PE ratio 85.2886
Dividend yield $0 (0%)
Earnings per share (TTM) $2.98

Compare stock trading platforms

Note: The dollar amounts in the table below are in Canadian dollars.

1 - 6 of 6
Name Product Finder Rating Stock Trading Fee Account Fee Available Asset Types Offer
CIBC Investor's Edge
Finder Rating:
★★★★★
4 / 5
$4.95 - $6.95
$0 if conditions met, otherwise $100/year
Stocks, Bonds, Options, Mutual Funds, ETFs
FREE TRADES
Wealthsimple Trade
Finder Rating:
★★★★★
3.9 / 5
$0
$0
Stocks, ETFs
Get 2 free stocks when you deposit and trade $150.
Scotia iTRADE
Finder Rating:
★★★★★
3.8 / 5
$4.99 - $9.99
$0
Bonds, Options, Mutual Funds, ETFs, GICs, International Equities
Interactive Brokers
Finder Rating:
★★★★★
4.1 / 5
Min. $1.00, Max. 0.5%
$0
Stocks, Bonds, Options, ETFs, Currencies, Futures
Questrade
Finder Rating:
★★★★★
4.2 / 5
$4.95 - $9.95
$0
Stocks, Bonds, Options, Mutual Funds, ETFs, GICs, International Equities, Precious Metals
Get $50 in free trades when you fund your account with a minimum of $1,000.
OFFER
Qtrade Direct Investing
Finder Rating:
★★★★★
4.1 / 5
$6.95 - $8.75
$0 if conditions met, otherwise $25/quarter
Stocks, Bonds, Options, Mutual Funds, ETFs, GICs
Get $500 in commission free trades when you fund your account with a minimum of $10,000. Conditions apply. Ends August 31st, 2022.
loading

Compare up to 4 providers

Online stock trading

Is it a good time to buy Abiomed stock?

The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.

Abiomed price performance over time

Historical closes compared with the close of $258.23 from 2022-05-17

1 week (2022-05-07) N/A
1 month (2022-04-14) -15.63%
3 months (2022-02-14) N/A
6 months (2021-11-18) -24.09%
1 year (2021-05-18) -5.40%
2 years (2020-05-18) 35.16%
3 years (2019-05-17) 260.48
5 years (2017-05-17) 97.82%

Is Abiomed under- or over-valued?

Valuing Abiomed stock is incredibly difficult, and any metric has to be viewed as part of a bigger picture of Abiomed's overall performance. However, analysts commonly use some key metrics to help gauge the value of a stock.

Abiomed's P/E ratio

Abiomed's current share price divided by its per-share earnings (EPS) over a 12-month period gives a "trailing price/earnings ratio" of roughly 85x. In other words, Abiomed shares trade at around 85x recent earnings.

That's relatively high compared to, say, the trailing 12-month P/E ratio for the NASDAQ 100 at the end of 2019 (27.29). The high P/E ratio could mean that investors are optimistic about the outlook for the shares or simply that they're over-valued.

Abiomed's PEG ratio

Abiomed's "price/earnings-to-growth ratio" can be calculated by dividing its P/E ratio by its growth – to give 2.75. A low ratio can be interpreted as meaning the shares offer better value, while a higher ratio can be interpreted as meaning the shares offer worse value.

The PEG ratio provides a broader view than just the P/E ratio, as it gives more insight into Abiomed's future profitability. By accounting for growth, it could also help you if you're comparing the share prices of multiple high-growth companies.

Abiomed's EBITDA

Abiomed's EBITDA (earnings before interest, taxes, depreciation and amortisation) is $284.4 million.

The EBITDA is a measure of a Abiomed's overall financial performance and is widely used to measure a its profitability.

Abiomed financials

Revenue TTM $1 billion
Operating margin TTM 24.88%
Gross profit TTM $843.6 million
Return on assets TTM 10.13%
Return on equity TTM 9.64%
Profit margin 13.23%
Book value $33.01
Market capitalisation $11.6 billion

TTM: trailing 12 months

Abiomed share dividends

We're not expecting Abiomed to pay a dividend over the next 12 months.

Have Abiomed's shares ever split?

Abiomed's shares were split on a 2:1 basis on 2 October 2000. So if you had owned 1 share the day before before the split, the next day you'd have owned 2 shares. This wouldn't directly have changed the overall worth of your Abiomed shares – just the quantity. However, indirectly, the new 50% lower share price could have impacted the market appetite for Abiomed shares which in turn could have impacted Abiomed's share price.

Abiomed share price volatility

Over the last 12 months, Abiomed's shares have ranged in value from as little as $227.25 up to $379.3. A popular way to gauge a stock's volatility is its "beta".

ABMD.US volatility(beta: 1.33)Avg. volatility(beta: 1.00)LowHigh

Beta is a measure of a share's volatility in relation to the market. The market (NASDAQ average) beta is 1, while Abiomed's is 1.325. This would suggest that Abiomed's shares are more volatile than the average for this exchange and represent, relatively-speaking, a higher risk (but potentially also market-beating returns).

Abiomed overview

Abiomed, Inc. engages in the research, development, and sale of medical devices to assist or replace the pumping function of the failing heart. It also provides a continuum of care to heart failure patients. The company offers Impella 2. 5, a percutaneous micro heart pump with integrated motor and sensors; and Impella CP, a device for use by interventional cardiologists to support patients in the cath lab, as well as by cardiac surgeons in the heart surgery suite. It also provides Impella 5. 0, Impella LD, and Impella 5.

Frequently asked questions


Disclaimer: This information should not be interpreted as an endorsement of futures, stocks, ETFs, options or any specific provider, service or offering. It should not be relied upon as investment advice or construed as providing recommendations of any kind. Futures, stocks, ETFs and options trading involves substantial risk of loss and therefore are not appropriate for all investors. Trading forex on leverage comes with a higher risk of losing money rapidly. Past performance is not an indication of future results. Consider your own circumstances, and obtain your own advice, before making any trades.

More on investing

More guides on Finder

Go to site